The AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Copenhagen, Denmark on March 17-21, 2026. The meeting brings together more than 5000 participants to share the latest developments for research, drug discovery, clinical trials, and treatments for Alzheimer’s and Parkinson’s disease.
With long experience in supporting pharma clients in drug discovery for neurodegenerative diseases, for example in proteopathy-focused target and lead discovery, Cellectricon is looking forward to taking part in this year’s meeting.
Stop by stand 91 in the exhibit hall to meet the Cellectricon team or to contact us to arrange a meeting onsite.
Johan Pihl
CSO
Meet us at AD/PD!
We are looking forward to taking part in this year’s meeting and for the opportunity to introduce our drug discovery services, and in particular our newly launched Neurotoxicity Testing Services, to prospective new partners. Get in touch if you are interested in setting up a meeting!